Blokees’ Figures from Multiple IPs Amaze Fans at 2024 Singapore Comic Con
SHANGHAI, Dec. 7, 2024 /PRNewswire/ — During the two-day 2024 Singapore Comic Con (December 7–8), Blokees unveiled its new Sesame Street collection for the first time globally and showcased an impressive array of figures. Blokees’ showcase at SGCC spans an impressive range of globally
Research Shows How Lifestyle Factors and Diet Affect Hematologic Care
Studies highlight interactions among lifestyle factors, disease development, and response to treatment SAN DIEGO, Dec. 7, 2024 /PRNewswire/ — Five studies presented during the 66th American Society of Hematology (ASH) Annual Meeting and Exposition reveal new linkages between blood disorders a
New Research from Children’s Hospital of Philadelphia to Transform Standard of Care Across the Globe for Newly Diagnosed Children with B-cell Acute Lymphoblastic Leukemia
Results will be presented at the 66th American Society of Hematology Annual Meeting PHILADELPHIA, Dec. 7, 2024 /PRNewswire/ — Researchers at Children’s Hospital of Philadelphia (CHOP) and the Children’s Oncology Group (COG) announced the results of a Phase 3 study that demonstrate
Seattle Children’s researchers greatly improve survival for children diagnosed with the most common form of childhood cancer, changing the standard of care
The findings will be presented during a scientific session at the American Society of Hematology Annual Meeting on Dec. 8 SEATTLE, Dec. 7, 2024 /PRNewswire/ — New findings set to be presented by Seattle Children’s Research Institute at the American Society of Hematology (ASH) Annual Mee
BLINCYTO® (BLINATUMOMAB) ADDED TO CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN NEWLY DIAGNOSED PEDIATRIC PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase 3 Study Results Demonstrated Three Year, Disease-Free Survival of 96% THOUSAND OAKS, Calif., Dec. 7, 2024 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced new data demonstrating that adding BLINCYTO® (blinatumomab) to chemotherapy significantly improves disease-free survival (DFS) in
Landmark Clinical Trial Results Offer New Hope for Kids with Acute Lymphoblastic Leukemia (ALL)
Transformative breakthrough in pediatric leukemia made possible by decades of St. Baldrick’s Foundation funding and support. SAN DIEGO, Dec. 7, 2024 /PRNewswire/ — Groundbreaking results from a major clinical trial, supported in part by the St. Baldrick’s Foundation, were unveiled
Putting Women & Children First to Optimize Their Hematology Health
Researchers report significant breakthroughs in prevention and treatment for blood disorders affecting women and children SAN DIEGO, Dec. 7, 2024 /PRNewswire/ — Emerging research findings presented during the 66th American Society of Hematology (ASH) Annual Meeting and Exposition highlight opp
Lawsuit for Investors who Lost over $100,000 in shares of DMC Global Inc. (NASDAQ: BOOM) between May and Nov. 2024 announced by Shareholders Foundation
SAN DIEGO, Dec. 7, 2024 /PRNewswire/ — The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in DMC Global Inc. (NASDAQ: BOOM) shares Investors who purchased more than $100,000 in shares of DMC Global Inc. (NASDAQ: BOOM) between May and November 2024 have c
zeb wins AWS Rising Star Partner of the Year – Consulting Award
zeb recognized by AWS for excellence in Cloud and AI innovation – Named with the Rising Star Partner of the Year Award LAS VEGAS, Dec. 7, 2024 /PRNewswire/ — zeb, a global leader in AI-powered digital transformation solutions, is proud to announce its recognition as the recipient of the AWS
Ethara: YAS ALL IN: A WEEKEND OF RACING, ENTERTAINMENT, AND ADVENTURE ACROSS THE WHOLE OF ABU DHABI DURING GRAND PRIX WEEKEND
As the emirate continues to build its profile as a global sporting hub, ticket-holders can maximise their time in the capital – from Yas Island theme parks to iconic cultural landmarks, as well other complimentary benefits ABU DHABI, UAE, Dec. 7, 2024 /PRNewswire/ — As major sporting events
